DAVID E COHN, M.D.
Medical Practice at Olentangy River Rd, Columbus, OH
License number
Ohio 35079462
Category
Medical Practice
Type
Gynecologic Oncology
Address
Address
1145 Olentangy River Rd, Columbus, OH 43212
Phone
(614) 293-3873
(614) 293-3078 (Fax)
(614) 293-3078 (Fax)
Personal information
See more information about DAVID E COHN at radaris.comName
Address
Phone
7410 Whispering Oak Dr, Sylvania, OH 43560
Organization information
See more information about DAVID E COHN at bizstanding.comGynecologic Oncology - David E Cohn MD
4775 Knightsbridge Blvd, Columbus, OH 43214
Industry:
Offices of Physicians, Except Mental Health
Doing business as:
Gynecologic Oncology
Site:
Phone:
(614) 293-3873 (Phone)
Manager:
Linda Havenar (Manager)
SIC:
8011 - Offices and Clinics of Doctors of Medicine
Categories:
Gynecology & Obstetrics Physicians & Surgeons, Oncology Physicians & Surgeons, Physicians & Surgeons
Company size:
4
Professional information
See more information about DAVID E COHN at trustoria.com
Dr. David E Cohn, Hilliard OH - MD (Doctor of Medicine)
Dr. David E Cohn, Hilliard OH - MD (Doctor of Medicine)
Specialties:
Gynecologic Oncology
Address:
Gyn Oncology at Mill Run
3651 Ridge Mill Dr, Hilliard 43026
(614) 529-6730 (Phone), (614) 293-3078 (Fax)
OSU Comprehensive Cancer Center
300 W 10Th Ave, Columbus 43210
(614) 293-3241 (Phone), (614) 293-4044 (Fax)
OSU Comprehensive Cancer Ctr
300 W 10Th Ave, Columbus 43210
(614) 293-8619 (Phone)
3651 Ridge Mill Dr, Hilliard 43026
(614) 529-6730 (Phone), (614) 293-3078 (Fax)
OSU Comprehensive Cancer Center
300 W 10Th Ave, Columbus 43210
(614) 293-3241 (Phone), (614) 293-4044 (Fax)
OSU Comprehensive Cancer Ctr
300 W 10Th Ave, Columbus 43210
(614) 293-8619 (Phone)
Certifications:
Gynecological Oncology, 2011, Obstetrics & Gynecology, 2012
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Gyn Oncology at Mill Run
3651 Ridge Mill Dr, Hilliard 43026
OSU Comprehensive Cancer Center
300 W 10Th Ave, Columbus 43210
OSU Comprehensive Cancer Ctr
300 W 10Th Ave, Columbus 43210
James Cancer Hospital and Solove Research Institute
300 West 10Th Ave, Columbus 43210
Wexner Medical Center at The Ohio State University
410 West 10Th Ave, Columbus 43210
3651 Ridge Mill Dr, Hilliard 43026
OSU Comprehensive Cancer Center
300 W 10Th Ave, Columbus 43210
OSU Comprehensive Cancer Ctr
300 W 10Th Ave, Columbus 43210
James Cancer Hospital and Solove Research Institute
300 West 10Th Ave, Columbus 43210
Wexner Medical Center at The Ohio State University
410 West 10Th Ave, Columbus 43210
Education:
Medical School
Georgetown University School Of Medicine
Graduated: 1994
University Of Wa School Of Med
Georgetown University School Of Medicine
Graduated: 1994
University Of Wa School Of Med
David Elliott Cohn, Hilliard OH
David Elliott Cohn, Hilliard OH
Specialties:
Gynecologic Oncologist
Address:
3651 Ridge Mill Dr, Hilliard, OH 43026
320 W 10Th Ave, Columbus, OH 43210
1145 Olentangy River Road, Columbus, OH 43212
320 W 10Th Ave, Columbus, OH 43210
1145 Olentangy River Road, Columbus, OH 43212
Education:
Doctor of Medicine
Board certifications:
American Board of Obstetrics and Gynecology Certification in Obstetrics & Gynecology, American Board of Obstetrics and Gynecology Sub-certificate in Gynecologic Oncology (Obstetrics & Gynecology)
Microrna-Based Methods And Compositions For The Diagnosis, Prognosis And Treatment Of Ovarian Cancer Using A Real-Time Pcr Platform
Microrna-Based Methods And Compositions For The Diagnosis, Prognosis And Treatment Of Ovarian Cancer Using A Real-Time Pcr Platform
US Patent:
2011027, Nov 10, 2011
Filed:
Mar 25, 2009
Appl. No.:
13/132583
Inventors:
David E. Cohn - Bexley OH, US
Kimberly Resnick - Shaker Hts. OH, US
Hansjuerg Alder - Columbus OH, US
Carlo M. Croce - Columbus OH, US
Kimberly Resnick - Shaker Hts. OH, US
Hansjuerg Alder - Columbus OH, US
Carlo M. Croce - Columbus OH, US
Assignee:
THE OHIO STATE UNIVERSITY - Columbus OH
International Classification:
C40B 30/04, G01N 33/574, C07H 21/02, C12Q 1/68
US Classification:
506 9, 435 612, 436501, 435 614, 536 231
Abstract:
Methods and compositions for the diagnosis, prognosis and/or treatment of ovarian cancer are disclosed.
Chimeric Vegf Peptides
Chimeric Vegf Peptides
US Patent:
8080253, Dec 20, 2011
Filed:
Feb 7, 2005
Appl. No.:
11/052721
Inventors:
Pravin Kaumaya - Westerville OH, US
David Cohn - Bexley OH, US
David Cohn - Bexley OH, US
Assignee:
The Ohio State University Research Foundation - Columbus OH
International Classification:
A61K 39/00, A61K 38/18, C07H 21/04
US Classification:
4241921, 4241841, 4241851, 514 81, 536 234
Abstract:
Compositions for and methods of treating patients with malignancies associated with overexpression of VEGF, particularly ovarian cancer are provided herein. The compositions include but are not limited to certain VEGF epitopes, multivalent peptides comprising the epitopes, and chimeric peptides comprising one or more of the epitopes and a T cell epitope.
Chimeric Vegf Peptides
Chimeric Vegf Peptides
US Patent:
2012012, May 17, 2012
Filed:
Dec 20, 2011
Appl. No.:
13/331891
Inventors:
Pravin Kaumaya - Westerville OH, US
David Cohn - Bexley OH, US
David Cohn - Bexley OH, US
Assignee:
THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION - Columbus OH
International Classification:
A61K 39/00, C07H 21/04, A61P 35/00, C07K 14/475
US Classification:
4241851, 530324, 536 235
Abstract:
Compositions for and methods of treating patients with malignancies associated with overexpression of VEGF, particularly ovarian cancer are provided herein. The compositions include but are not limited to certain VEGF epitopes, multivalent peptides comprising the epitopes, and chimeric peptides comprising one or more of the epitopes and a T cell epitope.
Chimeric Vegf Peptides
Chimeric Vegf Peptides
US Patent:
2013023, Sep 5, 2013
Filed:
May 3, 2013
Appl. No.:
13/886951
Inventors:
David Cohn - Bexley OH, US
International Classification:
A61K 39/00, C07K 14/12, C07K 14/475
US Classification:
4241851, 530300, 536 234
Abstract:
Compositions for and methods of treating patients with malignancies associated with overexpression of VEGF, particularly ovarian cancer, are provided herein. The compositions include but are not limited to certain VEGF epitopes, multivalent peptides comprising the epitopes, and chimeric peptides comprising one or more of the epitopes and a T cell epitope.